Pierre Dubédat

698 total citations
19 papers, 610 citations indexed

About

Pierre Dubédat is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Pierre Dubédat has authored 19 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 9 papers in Molecular Biology and 8 papers in Neurology. Recurrent topics in Pierre Dubédat's work include Neuroscience and Neuropharmacology Research (10 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and Receptor Mechanisms and Signaling (6 papers). Pierre Dubédat is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Parkinson's Disease Mechanisms and Treatments (8 papers) and Receptor Mechanisms and Signaling (6 papers). Pierre Dubédat collaborates with scholars based in France. Pierre Dubédat's co-authors include Alain Boireau, Thomas Boraud, Abdelhamid Benazzouz, Jean‐Marie Stutzmann, Christian E. Gross, Adam Doble, Mireille Meunier, S Parmentier, Pascal Barnéoud and Assunta Impérato and has published in prestigious journals such as Annals of the New York Academy of Sciences, Neuroscience and Journal of Neurochemistry.

In The Last Decade

Pierre Dubédat

17 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Dubédat France 14 369 293 170 107 62 19 610
Jean-Christophe Delumeau France 14 285 0.8× 346 1.2× 307 1.8× 29 0.3× 92 1.5× 20 800
Joachim Mierau Germany 13 294 0.8× 226 0.8× 266 1.6× 147 1.4× 19 0.3× 22 743
Seiichiro Shimazu Japan 15 240 0.7× 103 0.4× 157 0.9× 56 0.5× 42 0.7× 25 448
Ervin Horváth Germany 13 360 1.0× 71 0.2× 228 1.3× 44 0.4× 79 1.3× 19 600
Victor Garza United States 16 285 0.8× 104 0.4× 251 1.5× 53 0.5× 18 0.3× 20 602
Jean Rataud France 11 400 1.1× 96 0.3× 295 1.7× 69 0.6× 75 1.2× 19 618
D. Seemann Austria 8 185 0.5× 216 0.7× 86 0.5× 31 0.3× 41 0.7× 20 421
Helmut A. Ensinger Germany 13 255 0.7× 89 0.3× 337 2.0× 95 0.9× 26 0.4× 21 641
Susan M. Lotarski United States 13 247 0.7× 109 0.4× 253 1.5× 74 0.7× 35 0.6× 18 507
Sandrine Ferry France 7 367 1.0× 270 0.9× 242 1.4× 86 0.8× 13 0.2× 7 653

Countries citing papers authored by Pierre Dubédat

Since Specialization
Citations

This map shows the geographic impact of Pierre Dubédat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Dubédat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Dubédat more than expected).

Fields of papers citing papers by Pierre Dubédat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Dubédat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Dubédat. The network helps show where Pierre Dubédat may publish in the future.

Co-authorship network of co-authors of Pierre Dubédat

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Dubédat. A scholar is included among the top collaborators of Pierre Dubédat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Dubédat. Pierre Dubédat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Böhme, Georg Andrees, Sharon R. Letchworth, Gregory J. Gatto, et al.. (2004). In vitro and in vivo characterization of TC‐1827, a novel brain α4β2 nicotinic receptor agonist with pro‐cognitive activity. Drug Development Research. 62(1). 26–40. 10 indexed citations
2.
Boireau, Alain, et al.. (2000). The protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP+ accumulation. Neuropharmacology. 39(6). 1016–1020. 27 indexed citations
3.
Boireau, Alain, et al.. (2000). The anti-oxidant ebselen antagonizes the release of the apoptogenic factor cytochrome c induced by Fe2+/citrate in rat liver mitochondria. Neuroscience Letters. 289(2). 95–98. 20 indexed citations
4.
Boireau, Alain, et al.. (1999). Effects of Ebselen, a Glutathione Peroxidase Mimic, in Several Models of Mitochondrial Dysfunction. Annals of the New York Academy of Sciences. 893(1). 254–257. 15 indexed citations
5.
Boireau, Alain, et al.. (1997). Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in mice. Neuroscience Letters. 234(2-3). 123–126. 25 indexed citations
6.
Barnéoud, Pascal, et al.. (1996). Neuroprotective effects of riluzole on a model of parkinson's disease in the rat. Neuroscience. 74(4). 971–983. 67 indexed citations
7.
Benazzouz, Abdelhamid, Thomas Boraud, Pierre Dubédat, et al.. (1995). Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study. European Journal of Pharmacology. 284(3). 299–307. 205 indexed citations
8.
Barnéoud, Pascal, et al.. (1995). Effects of complete and partial lesions of the dopaminergic mesotelencephalic system on skilled forelimb use in the rat. Neuroscience. 67(4). 837–848. 65 indexed citations
9.
Boireau, Alain, et al.. (1995). Methamphetamine and dopamine neurotoxicity: differential effects of agents interfering with glutamatergic transmission. Neuroscience Letters. 195(1). 9–12. 16 indexed citations
10.
Boireau, Alain, et al.. (1994). Riluzole and experimental parkinsonism. Neuroreport. 5(18). 2657–2660. 51 indexed citations
11.
Boireau, Alain, et al.. (1994). Riluzole and experimental parkinsonism. Neuroreport. 5(16). 2157–2160. 35 indexed citations
12.
Piot, O., P Chaillou, Alain Boireau, et al.. (1992). CHRONIC CYCLOPYRROLONE TREATMENT DOES NOT INDUCE PHYSICAL DEPENDENCE IN MICE.. Clinical Neuropharmacology. 15. 637B–637B.
13.
Castel, Marie‐Noëlle, et al.. (1991). Identification of Intact Neurotensin in the Substantia Nigra After Its Retrograde Axonal Transport in Dopaminergic Neurons. Journal of Neurochemistry. 56(5). 1816–1818. 26 indexed citations
14.
Boireau, Alain, Fabien Richard, Valérie Olivier, et al.. (1991). Differential Effects of Potassium Channel Blockers on Dopamine Release from Rat Striatal Slices. Journal of Pharmacy and Pharmacology. 43(11). 798–801. 13 indexed citations
15.
Boireau, Alain, Pierre Dubédat, Pierre M. Laduron, Adam Doble, & J.C. Blanchard. (1990). Preferential Decrease in Dopamine Utilization in Prefrontal Cortex by Zopiclone, Diazepam and Zolpidem in Unstressed Rats. Journal of Pharmacy and Pharmacology. 42(8). 562–565. 15 indexed citations
16.
Boireau, Alain, Pierre Dubédat, P M Laduron, et al.. (1990). Effects of RP 60180, a kappa-receptor agonist, on dopamine metabolism and utilization in rat and guinea-pig brain. European Journal of Pharmacology. 183(6). 2330–2330. 1 indexed citations
17.
18.
Boireau, Alain, et al.. (1986). Enhancing effect of dopamine blockers on evoked acetylcholine release in rat striatal slices: a classical D-2 antagonist response?. European Journal of Pharmacology. 128(1-2). 93–98. 14 indexed citations
19.
Rémy, Jean-Serge, et al.. (1975). [Effects of lethal overexposure on gastric secretion in the pig].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 150(5). 532–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean-Christophe Delumeau Breakdown of academic impact, for papers by Joachim Mierau Breakdown of academic impact, for papers by Seiichiro Shimazu Breakdown of academic impact, for papers by Ervin Horváth Breakdown of academic impact, for papers by Victor Garza Breakdown of academic impact, for papers by Jean Rataud Breakdown of academic impact, for papers by D. Seemann Breakdown of academic impact, for papers by Helmut A. Ensinger Breakdown of academic impact, for papers by Susan M. Lotarski Breakdown of academic impact, for papers by Sandrine Ferry
Rankless by CCL
2026